To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC21000 | ESI-05 Featured |
ESI-05 is a potent EAPC2-specific antagonist that inhibits cAMP-mediated EPAC2 GEF activity with apparent IC50 of 0.43 uM.
More description
|
|
| DC21180 | JNJ-47965567 Featured |
JNJ-47965567 is a potent, selective, centrally permeable P2X7 receptor antagonist with pKi of 7.9 and 8.7 for human and rat P2X7, respectively.
More description
|
|
| DC21282 | MJN110 Featured |
MJN110 (MJN-110) is a potent, selective, and orally active MAGL inhibitor with IC50 of 2.1 nM (2-AG hydrolysis).
More description
|
|
| DC21205 | KT-109 Featured |
KT-109 is a potent, selective inhibitor of DAGLβ with IC50 of 42 nM, displays about 60-fold selectivity over DAGLα.
More description
|
|
| DC21448 | Apicidin Featured |
Apicidin (OSI 2040) is a fungal metabolite that exhibits potent, broad spectrum antiprotozoal activity in vitro, potently inhibits HDAC with IC50 of 0.7 nM in an enzyme activity assay.
More description
|
|
| DC21689 | SR 142948A Featured |
A potent, selective and orally active neurotensin receptor antagonist with IC50 of 1.19 nM.
More description
|
|
| DC11521 | Dotinurad Featured |
Dotinurad is a novel compound that exhibits a remarkable uric acid excretion-promoting action.
More description
|
|
| DC21781 | UPCDC30245 Featured |
UPCDC30245 is an allosteric inhibitor of AAA ATPase p97 with IC50 of 27 nM, binds at the junction between the D1 and D2 domains of p97..
More description
|
|
| DC21853 | Ogerin Featured |
A selective GPR68 positive allosteric modulator (pEC50=6.83) with minimal PAM activity at the related proton-sensing GPCRs GPR4 and GPR65.
More description
|
|
| DC22132 | KY-05009 Featured |
KY-05009 (KY05009) is a potent, ATP-competitive inhibitor of Traf2- and Nck-interacting kinase (TNIK) with Ki of 100 nM.
More description
|
|
| DC26073 | BMS-986122 Featured |
BMS-986122 is a potent positive allosteric modulator of μ-opioid receptor, significantly increases the inhibition of forskolin-stimulated adenylyl cyclase activity produced by an EC10 (30 pM) concentration of endomorphin-I in CHO-μ cells..
More description
|
|
| DC26084 | LE-135 Featured |
LE135 is a retinoid acid receptor antagonist, produces pain through direct activation of TRP channels.
More description
|
|
| DC36086 | Atpenin A5 Featured |
Atpenin A5, an antifungal antibiotic, is an ubiquinone-binding site inhibitor of succinate dehydrogenase. Atpenin A5 has cardioprotective effects against simulated ischemia-reperfusion injury in cardiomyocytes.
More description
|
|
| DC10349 | Sumanirole maleate Featured |
Sumanirole maleate(PNU 95666E; U95666E) is a highly selective D2 receptor full agonist with an ED50 of about 46 nM.
More description
|
|
| DC10363 | Coumestrol Featured |
Coumestrol, a phytoestrogen present in soybean products, exhibits activities against cancers, neurological disorders, and autoimmune diseases. It suppresses proliferation of ES2 cells with an IC50 of 50 μM.
More description
|
|
| DC9078 | Fluoxetine Hydrochloride Featured |
Fluoxetine HCl is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class.
More description
|
|
| DC11310 | MST312 Featured |
MST312 is a telomerase inhibitor (IC50 = 0.67 μM in a TRAP assay).
More description
|
|
| DC11319 | TPMPA Featured |
TPMPA is a GABAA-ρ1 (ρ1 GABAC) receptor antagonist that is 8-fold selective for GABAA-ρ1 over GABAA-ρ2 (ρ2 GABAC) receptors expressed in X.
More description
|
|
| DC33476 | Antihelmycin |
Hygromycin B is a protein translocation inhibitor that suppresses protein and RNA synthesis of bacteria. and viruses by inducing misreadings during translation.
More description
|
|
| DC11330 | LY320135 Featured |
LY320135 is a selective cannabinoid (CB) receptor 1 antagonist (Kis = 224 and >10,000 nM for CB1 and CB2, respectively, in vitro).
More description
|
|
| DC11376 | SKA-121 Featured |
SKA-121 is a positive-gating modulator of intermediate-conductance calcium-activated potassium channels (IKCa1/KCa3.1) with an EC50 value of 109 nM using whole-cell patch-clamp electrophysiology with calcium in the internal solution.
More description
|
|
| DC11503 | KDOAM-25 Featured |
A potent, selective KDM5 sub-family(JARID1) inhibitor with biochemical IC50 of 71/19/69/69 nM for KDM5A/B/C/D, respectively.
More description
|
|
| DC11640 | PK-11195 Featured |
PK 11195 is a ligand of translocator protein. It targets Leishmania chemotherapy (IC50s of 14.2 μM, 8.2 μM, 3.5 μM for L. amazonensis, L. major and L. braziliensis, respectively).
More description
|
|
| DC11643 | Olomoucine Featured |
A potent, ATP-competetive CDKs inhibitor with IC50 of 7, 7, 7, 3 uM for Cdc2/cyclin B, Cdk2/cyclin A, Cdk2/cyclin E, and Cdk/p35 kinase.
More description
|
|
| DC11747 | Iperoxo |
Iperoxo is a superagonist of the muscarinic acetylcholine receptors and an OxotremorineM analog.
More description
|
|
| DC11753 | BL-1249 Featured |
BL-1249 is a nonsteroidal anti-inflammatory drug (NSAID) and a potassium channel activator. BL-1249 exhibits more selective for the bladder (EC50 of 1.26 μM) than vascular tissue (EC50 of 21.0 μM). BL-1249 extracellular application activates all TREK subfamily members but has no effect on other K2P subfamilies. BL-1249 potently activates K2P2.1 (TREK-1) and K2P10.1 (TREK-2) with EC50 values of 5.5 μM and 8.0 μM, respectively
More description
|
|
| DC12068 | Fosmidomycin sodium salt Featured |
Fosmidomycin sodium salt is a phosphonic acid antibiotic and a antimalarial drug, which is active against both Gram-negative and Gram-positive bacteria.
More description
|
|
| DC12086 | AC-55649 Featured |
AC-55649 is a potent, highly isoform-selective agonist of human RARβ2 receptor, with a pEC50 of 6.9.
More description
|
|
| DC12096 | Pinacidil monohydrate (Pinacidil hydrate) Featured |
Pinacidil monohydrate, an antihypertensive drug, is a potassium channel activator.
More description
|
|
| DC12216 | Dodecanoylcarnitine Featured |
Dodecanoylcarnitine is present in fatty acid oxidation disorders such as long-chain acyl CoA dehydrogenase deficiency, carnitine palmitoyltransferase I/II deficiency, and is also associated with celiac disease.
More description
|
|